BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33794249)

  • 1. Behavior and electrophysiology studies of the peripheral neuropathy induced by individual and co-administration of paclitaxel and oxaliplatin in rat.
    Paniagua N; Sánchez-Robles EM; Bagues A; Martín-Fontelles MI; Goicoechea C; Girón R
    Life Sci; 2021 Jul; 277():119397. PubMed ID: 33794249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.
    Xiao WH; Bennett GJ
    Pain; 2012 Mar; 153(3):704-709. PubMed ID: 22244441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.
    Xiao WH; Zheng H; Bennett GJ
    Neuroscience; 2012 Feb; 203():194-206. PubMed ID: 22200546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats.
    Nakamura H; Kawashiri T; Kobayashi D; Uchida M; Egashira N; Shimazoe T
    Biol Pharm Bull; 2021; 44(2):271-274. PubMed ID: 33518680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat.
    Ling B; Coudoré-Civiale MA; Balayssac D; Eschalier A; Coudoré F; Authier N
    Toxicology; 2007 May; 234(3):176-84. PubMed ID: 17418472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].
    Taguchi K
    Yakugaku Zasshi; 2016; 136(2):287-96. PubMed ID: 26831807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of synthetic eel calcitonin, elcatonin, on cold and mechanical allodynia induced by oxaliplatin and paclitaxel in rats.
    Aoki M; Mori A; Nakahara T; Sakamoto K; Ishii K
    Eur J Pharmacol; 2012 Dec; 696(1-3):62-9. PubMed ID: 23001015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin treatment changes the function of sensory nerves in rats.
    Yamamoto S; Ono H; Kume K; Ohsawa M
    J Pharmacol Sci; 2016 Apr; 130(4):189-93. PubMed ID: 26790975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants.
    Tsubota M; Fukuda R; Hayashi Y; Miyazaki T; Ueda S; Yamashita R; Koike N; Sekiguchi F; Wake H; Wakatsuki S; Ujiie Y; Araki T; Nishibori M; Kawabata A
    J Neuroinflammation; 2019 Oct; 16(1):199. PubMed ID: 31666085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions targeting Wnt/β-catenin signaling pathway attenuate paclitaxel-induced peripheral neuropathy.
    Resham K; Sharma SS
    Eur J Pharmacol; 2019 Dec; 864():172714. PubMed ID: 31586636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Transcriptome of Dorsal Root Ganglia Reveals Distinct Etiologies of Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy in Rats.
    Sun W; Hao Y; Li R; Ho IHT; Wu S; Li N; Ba X; Wang J; Xiong D; Jiang C; Xiao L; Liu X
    Neuroscience; 2023 Apr; 516():1-14. PubMed ID: 36822350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
    Joseph EK; Chen X; Bogen O; Levine JD
    J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.
    Flatters SJL; Bennett GJ
    Pain; 2006 Jun; 122(3):245-257. PubMed ID: 16530964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY).
    Tanioka H; Nagasaka T; Uno F; Inoue M; Okita H; Katata Y; Kanzaki H; Kuramochi H; Satake H; Shindo Y; Doi A; Nasu J; Yamashita H; Yamaguchi Y
    BMC Cancer; 2019 Oct; 19(1):941. PubMed ID: 31604467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016).
    Ueno T; Endo K; Hori K; Ozaki N; Tsuji A; Kondo S; Wakisaka N; Murono S; Kataoka K; Kato Y; Yoshizaki T
    Int J Nanomedicine; 2014; 9():3005-12. PubMed ID: 24971011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi.
    Mizuno K; Shibata K; Komatsu R; Omiya Y; Kase Y; Koizumi S
    Cancer Biol Ther; 2016 Nov; 17(11):1206-1212. PubMed ID: 27416484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmon calcitonin reduces oxaliplatin-induced cold and mechanical allodynia in rats.
    Aoki M; Mori A; Nakahara T; Sakamoto K; Ishii K
    Biol Pharm Bull; 2013; 36(2):326-9. PubMed ID: 23370362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies.
    Toyama S; Shimoyama N; Ishida Y; Koyasu T; Szeto HH; Shimoyama M
    Anesthesiology; 2014 Feb; 120(2):459-73. PubMed ID: 24064792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of substance P in peripheral neuropathy induced by paclitaxel but not oxaliplatin.
    Tatsushima Y; Egashira N; Kawashiri T; Mihara Y; Yano T; Mishima K; Oishi R
    J Pharmacol Exp Ther; 2011 Apr; 337(1):226-35. PubMed ID: 21233199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy.
    Cao Y; Chang Q; Zhang W; Ornatsky O; Hedley D; Chen EX
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1195-1200. PubMed ID: 31520102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.